Ascendis Pharma A/S (ASND) Stock Overview
Explore Ascendis Pharma A/S’s financial performance, market position, analyst ratings, and future outlook.
Ascendis Pharma A/S (ASND)
Key Financials
Key Financials
Market Cap
16.7B
P/E Ratio
28.51
EPS (TTM)
$-2.42
ROE
-56.42%
ASND Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Ascendis Pharma A/S (ASND) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 62.39, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $211.40.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 28.51 and a market capitalization of 16.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.